116 related articles for article (PubMed ID: 8203777)
21. Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases.
Arboix A; Besses C; Acín P; Massons JB; Florensa L; Oliveres M; Sans-Sabrafen J
Stroke; 1995 Aug; 26(8):1463-6. PubMed ID: 7631354
[TBL] [Abstract][Full Text] [Related]
22. The paradox of bleeding and thrombosis in thrombocythemia: is von Willebrand factor the link?
van Genderen PJ; Leenknegt H; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):385-9. PubMed ID: 9263356
[TBL] [Abstract][Full Text] [Related]
23. [A case of cerebral venous thrombosis associated with thrombocythemia].
Takeuchi S; Takasato Y; Masaoka H; Hayakawa T; Otani N; Yoshino Y; Yatsushige H; Sugawara T
No Shinkei Geka; 2009 Jul; 37(7):697-702. PubMed ID: 19621780
[TBL] [Abstract][Full Text] [Related]
24. Erythromelalgia and thrombocythemia: a disease of platelet prostaglandin metabolism--thesis, Rotterdam, 1981.
Michiels JJ
Semin Thromb Hemost; 1997; 23(4):335-8. PubMed ID: 9263349
[No Abstract] [Full Text] [Related]
25. [What vascular events suggest a myeloproliferative disorder?].
Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
[TBL] [Abstract][Full Text] [Related]
26. Thrombocythemia as a cause of erythermalgia.
Redding KG
Arch Dermatol; 1977 Apr; 113(4):468-71. PubMed ID: 848975
[TBL] [Abstract][Full Text] [Related]
27. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
[TBL] [Abstract][Full Text] [Related]
28. Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.
Kim KT; Sohn SI; Cho KH
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):913.e9-10. PubMed ID: 22305797
[TBL] [Abstract][Full Text] [Related]
29. [Cerebrovascular disease in aged patients with polycythemia or thrombocythemia].
Akiguchi I; Shio H; Suzuki G; Kameyama M
Nihon Ronen Igakkai Zasshi; 1985 Mar; 22(2):93-9. PubMed ID: 4010043
[No Abstract] [Full Text] [Related]
30. Platelet hyperaggregability and thrombosis in patients with thrombocythemia.
Wu KK
Ann Intern Med; 1978 Jan; 88(1):7-11. PubMed ID: 619762
[TBL] [Abstract][Full Text] [Related]
31. Thrombocytosis, coronary thrombosis and acute myocardial infarction.
Virmani R; Popovsky MA; Roberts WC
Am J Med; 1979 Sep; 67(3):498-506. PubMed ID: 474596
[TBL] [Abstract][Full Text] [Related]
32. Erythromelalgia and thrombocythemia: a causal relation.
Michiels JJ; van Joost T
J Am Acad Dermatol; 1990 Jan; 22(1):107-11. PubMed ID: 2405024
[No Abstract] [Full Text] [Related]
33. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
34. Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide.
Schwarz J; Ovesná P; Černá O; Kissová J; Maaloufová Soukupová J; Brychtová Y; Doubek M; Červinek L; Cmunt E; Dulíček P; Campr V; Křen L; Penka M;
Eur J Haematol; 2016 Jan; 96(1):98-106. PubMed ID: 25807961
[TBL] [Abstract][Full Text] [Related]
35. Aspirin Responsive Thrombotic Complications in Thrombocythemia Vera. A Novel Platelet-Mediated Arterial Thrombophilia.
Michiels JJ
Turk J Haematol; 2002 Jun; 19(2):225-33. PubMed ID: 27264763
[TBL] [Abstract][Full Text] [Related]
36. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
37. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.
Cortelazzo S; Finazzi G; Ruggeri M; Vestri O; Galli M; Rodeghiero F; Barbui T
N Engl J Med; 1995 Apr; 332(17):1132-6. PubMed ID: 7700286
[TBL] [Abstract][Full Text] [Related]
38. [Vascular complications of essential thrombocythemia].
Bellucci S
Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
[TBL] [Abstract][Full Text] [Related]
39. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
40. Erythromelalgia without thrombocythemia.
Alarcón-Segovia D
Ann Intern Med; 1985 Sep; 103(3):473. PubMed ID: 4026098
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
